A standalone bioreactor system to deliver compressive load under perfusion flow to hBMSC-seeded 3D chitosan-graphene templates

Sci Rep. 2019 Nov 14;9(1):16854. doi: 10.1038/s41598-019-53319-7.

Abstract

The availability of engineered biological tissues holds great potential for both clinical applications and basic research in a life science laboratory. A prototype standalone perfusion/compression bioreactor system was proposed to address the osteogenic commitment of stem cells seeded onboard of 3D chitosan-graphene (CHT/G) templates. Testing involved the coordinated administration of a 1 mL/min medium flow rate together with dynamic compression (1% strain at 1 Hz; applied twice daily for 30 min) for one week. When compared to traditional static culture conditions, the application of perfusion and compression stimuli to human bone marrow stem cells using the 3D CHT/G template scaffold induced a sizable effect. After using the dynamic culture protocol, there was evidence of a larger number of viable cells within the inner core of the scaffold and of enhanced extracellular matrix mineralization. These observations show that our novel device would be suitable for addressing and investigating the osteogenic phenotype commitment of stem cells, for both potential clinical applications and basic research.

MeSH terms

  • Biomechanical Phenomena
  • Bioreactors*
  • Cell Culture Techniques / instrumentation*
  • Cell Differentiation / drug effects
  • Cells, Cultured
  • Chitosan / chemistry
  • Chitosan / pharmacology*
  • Extracellular Matrix / chemistry
  • Extracellular Matrix / drug effects
  • Graphite / chemistry
  • Graphite / pharmacology*
  • Humans
  • Mechanotransduction, Cellular / physiology
  • Mesenchymal Stem Cells / cytology
  • Mesenchymal Stem Cells / drug effects*
  • Mesenchymal Stem Cells / physiology
  • Perfusion / methods
  • Rheology
  • Tissue Engineering / instrumentation
  • Tissue Engineering / methods*
  • Tissue Scaffolds

Substances

  • Graphite
  • Chitosan